BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11533153)

  • 21. Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virus.
    Garulli B; Kawaoka Y; Castrucci MR
    J Virol; 2004 Jan; 78(2):1020-5. PubMed ID: 14694134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogene.
    Efferson CL; Schickli J; Ko BK; Kawano K; Mouzi S; Palese P; García-Sastre A; Ioannides CG
    J Virol; 2003 Jul; 77(13):7411-24. PubMed ID: 12805440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
    Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M
    J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards new mycobacterial vaccines.
    Gicquel B
    Dev Biol Stand; 1994; 82():171-8. PubMed ID: 7958472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defense mechanisms against influenza virus infection in the respiratory tract mucosa.
    Tamura S; Kurata T
    Jpn J Infect Dis; 2004 Dec; 57(6):236-47. PubMed ID: 15623947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice.
    Ferko B; Stasakova J; Sereinig S; Romanova J; Katinger D; Niebler B; Katinger H; Egorov A
    J Virol; 2001 Oct; 75(19):8899-908. PubMed ID: 11533153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.
    Cukalac T; Moffat JM; Venturi V; Davenport MP; Doherty PC; Turner SJ; Stambas J
    Vaccine; 2009 Nov; 27(48):6755-61. PubMed ID: 19744584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment.
    Kittel C; Ferko B; Kurz M; Voglauer R; Sereinig S; Romanova J; Stiegler G; Katinger H; Egorov A
    J Virol; 2005 Aug; 79(16):10672-7. PubMed ID: 16051859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells.
    Sistigu A; Bracci L; Valentini M; Proietti E; Bona R; Negri DR; Ciccaglione AR; Tritarelli E; Nisini R; Equestre M; Costantino A; Marcantonio C; Santini SM; Lapenta C; Donati S; Tataseo P; Miceli M; Cara A; Federico M
    Vaccine; 2011 Apr; 29(18):3465-75. PubMed ID: 21382480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
    Jiang JQ; Patrick A; Moss RB; Rosenthal KL
    J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells.
    Hinkula J; Walther-Jallow L; Laurén A; Mäkitalo B; Oberg M; Wahren B; Fenyö EM; Spetz AL
    Vaccine; 2009 Oct; 27(46):6424-31. PubMed ID: 19549607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses.
    García-Sastre A
    Virology; 2001 Jan; 279(2):375-84. PubMed ID: 11162793
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses.
    Blazevic V; Trubey CM; Shearer GM
    Hum Immunol; 2000 Sep; 61(9):845-9. PubMed ID: 11053627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfectant influenza viruses as antigen delivery vectors.
    García-Sastre A
    Adv Virus Res; 2000; 55():579-97. PubMed ID: 11050958
    [No Abstract]   [Full Text] [Related]  

  • 35. Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity.
    Zürcher T; Marión RM; Ortín J
    J Virol; 2000 Sep; 74(18):8781-4. PubMed ID: 10954584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus.
    Cromwell MA; Veazey RS; Altman JD; Mansfield KG; Glickman R; Allen TM; Watkins DI; Lackner AA; Johnson RP
    J Virol; 2000 Sep; 74(18):8762-6. PubMed ID: 10954580
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.